• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Biologic Therapy Market

    ID: MRFR/HC/11585-HCR
    100 Pages
    MRFR Team
    October 2025

    United States Biologic Therapy Market Research Report to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Biologic Therapy Market Infographic
    Purchase Options

    US Biologic Therapy Market Summary

    The US Biologic Therapy market is projected to experience substantial growth from 235.94 USD Billion in 2024 to 541.32 USD Billion by 2035.

    Key Market Trends & Highlights

    US Biologic Therapy Key Trends and Highlights

    • The US Biologic Therapy market is valued at 235.94 USD Billion in 2024.
    • By 2035, the market is expected to reach 541.32 USD Billion, indicating robust growth.
    • The compound annual growth rate (CAGR) for the market from 2025 to 2035 is estimated at 7.84%.
    • Growing adoption of biologic therapies due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 235.94 (USD Billion)
    2035 Market Size 541.32 (USD Billion)
    CAGR (2025 - 2035) 7.84%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Biologic Therapy Market market include

    Report Scope

    Report Attribute/Metric Details
     Market Size 2022 USD 382.85 billion
     Market Size 2023 USD 419.22 billion
    Market Size 2032 USD 998.36 billion
    Compound Annual Growth Rate (CAGR) 9.32% (2023- 2032)
    Base Year 2022
    Forecast Period 2023- 2032
    Historical Data 2019 & 2020,2021
    Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product Type, Therapy, Application, End User and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Samsung Biologics (South Korea), Amgen Inc (US), Novo Nordisk A/S (Denmark), Sanofi (France), Johnson & Johnson Services, Inc (US) ,Celltrion Healthcare Co., Ltd (South Korea) , Bristol-Myers Squibb Company (US), Eli Lilly and Company (US), F. Hoffmann La-Roche Ltd (Switzerland), Aeglea BioTherapuetics (US)
    Key Market Opportunities ·       Increasing number of pipeline products
    Key Market Driver ·       Increasing prevalence of cancer

    FAQs

    What is the expected market size of the US Biologic Therapy Market in 2024?

    The US Biologic Therapy Market is expected to be valued at 64.8 billion USD in 2024.

    What is the projected market size for the US Biologic Therapy Market in 2035?

    The market value for the US Biologic Therapy Market is projected to reach 94.5 billion USD by 2035.

    What is the expected compound annual growth rate (CAGR) for the US Biologic Therapy Market from 2025 to 2035?

    The expected CAGR for the US Biologic Therapy Market from 2025 to 2035 is 3.489 percent.

    Which therapy type is expected to have the largest market share in the US Biologic Therapy Market by 2035?

    Monoclonal Antibodies are expected to have the largest market share, valued at 36.0 billion USD by 2035.

    What is the market value for Vaccines in the US Biologic Therapy Market for 2024?

    The market value for Vaccines in the US Biologic Therapy Market is expected to reach 18.0 billion USD in 2024.

    Who are some key players in the US Biologic Therapy Market?

    Major players in the US Biologic Therapy Market include Biogen, Celgene, Amgen, Pfizer, and Bristol Myers Squibb.

    What is the market size for Cell Therapy in the US Biologic Therapy Market in 2024?

    Cell Therapy is expected to be valued at 12.0 billion USD in the US Biologic Therapy Market in 2024.

    What are the anticipated market figures for Gene Therapy by 2035?

    Gene Therapy is projected to reach a market value of 13.5 billion USD by 2035.

    What factors are driving the growth of the US Biologic Therapy Market?

    The growth drivers for the US Biologic Therapy Market include advancements in medical technology and increasing demand for personalized medicine.

    What challenges might impact the US Biologic Therapy Market in the coming years?

    Challenges impacting the market may include regulatory hurdles and high costs associated with biologic therapies.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials